Evaluating drugs after their approval for clinical use. Ray WA, Griffin MR, Avorn J (1993) N Engl J Med 329: 2029-32 Making medicines safer--the need for an independent drug safety board. Wood AJ, Stein CM, Woosley R (1998) N Engl J Med 339: 1851-4 Reform of drug regulation--beyond an independent drug-safety board. Ray WA, Stein CM (2006) N Engl J Med 354: 194-201 COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR (2002) Lancet 360: 1071-3 Postmarketing surveillance for drug safety: surely we can do better. Griffin MR, Stein CM, Ray WA (2004) Clin Pharmacol Ther 75: 491-4 Development of a System for Postmarketing Population Pharmacokinetic and Pharmacodynamic Studies Using Real-World Data From Electronic Health Records. Choi L, Beck C, McNeer E, Weeks HL, Williams ML, James NT, Niu X, Abou-Khalil BW, Birdwell KA, Roden DM, Stein CM, Bejan CA, Denny JC, Van Driest SL (2020) Clin Pharmacol Ther 107: 934-943 Use of Medicaid data for pharmacoepidemiology. Ray WA, Griffin MR (1989) Am J Epidemiol 129: 837-49 Adverse drug reactions and the elderly. Ray WA, Griffin MR, Shorr RI (1990) Health Aff (Millwood) 9: 114-22 In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers. Cai C, Fang J, Guo P, Wang Q, Hong H, Moslehi J, Cheng F (2018) J Chem Inf Model 58: 943-956 Adherence to disease-modifying antirheumatic drugs and the effects of exposure misclassification on the risk of hospital admission. Grijalva CG, Kaltenbach L, Arbogast PG, Mitchel EF, Griffin MR (2010) Arthritis Care Res (Hoboken) 62: 730-4 Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records. Liu M, McPeek Hinz ER, Matheny ME, Denny JC, Schildcrout JS, Miller RA, Xu H (2013) J Am Med Inform Assoc 20: 420-6 Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors. Jerome RN, Pulley JM, Roden DM, Shirey-Rice JK, Bastarache LA, R Bernard G, B Ekstrom L, Lancaster WJ, Denny JC (2018) Drug Saf 41: 303-311 Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis. Grijalva CG, Chung CP, Arbogast PG, Stein CM, Mitchel EF, Griffin MR (2007) Med Care 45: S66-76
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.